Revision history of "12012 — MIMEDI" (Q3698691)

20 March 2024

• curprev 11:0211:02, 20 March 2024‎ DG Regio talk contribs‎ 49,384 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.4071671743963124

7 December 2023

• curprev 12:0912:09, 7 December 2023‎ DG Regio talk contribs‎ 49,096 bytes −62‎ ‎Changed an Item

11 June 2023

• curprev 09:5209:52, 11 June 2023‎ Admin talk contribs‎ 49,158 bytes +352‎ BatchIngestion

8 June 2023

• curprev 07:4707:47, 8 June 2023‎ DG Regio talk contribs‎ 48,806 bytes +526‎ ‎Changed an Item

10 March 2023

• curprev 09:0209:02, 10 March 2023‎ DG Regio talk contribs‎ 48,280 bytes +1,903‎ ‎Changed an Item
• curprev 09:0209:02, 10 March 2023‎ DG Regio talk contribs‎ 46,377 bytes −507‎ ‎Removed claim: info Regio url (P1742): https://ec.europa.eu/regional_policy/projects/projects-database/mimedi-optimiser-la-fabrication-de-medicaments-innovants-en-evitant-le-recours-aux-salles-blanches_en, removed property P1742

9 March 2023

• curprev 13:2113:21, 9 March 2023‎ DG Regio talk contribs‎ 46,884 bytes +507‎ ‎Changed an Item
• curprev 13:2113:21, 9 March 2023‎ DG Regio talk contribs‎ 46,377 bytes −1,052‎ ‎Removed claim: image url (P851): https://ec.europa.eu/regional_policy/rest/projects/upload/4607.jpg, removed property P851
• curprev 13:2113:21, 9 March 2023‎ DG Regio talk contribs‎ 47,429 bytes −496‎ ‎Removed claim: info Regio url (P1742): https://ec.europa.eu/regional_policy/en/projects/europe/mimedi-optimiser-la-fabrication-de-medicaments-innovants-en-evitant-le-recours-aux-salles-blanches, removed property P1742
• curprev 13:2113:21, 9 March 2023‎ DG Regio talk contribs‎ 47,925 bytes −344‎ ‎Removed claim: ID used by InfoRegio (P1741): 4607, removed property P1741

11 August 2022

• curprev 23:0823:08, 11 August 2022‎ DG Regio talk contribs‎ 48,269 bytes +35,724‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, it, hr, el, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,

16 May 2022

• curprev 21:3021:30, 16 May 2022‎ DG Regio talk contribs‎ 12,545 bytes +1,404‎ ‎Changed an Item: Adding English translations
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 11,141 bytes −326‎ ‎Removed claim: French Kohesio ID (P843): 10341
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 11,467 bytes −1,404‎ ‎Removed claim: summary (P836): Innovative (medium) medicines have recently emerged in order to offer new treatment solutions for patients with therapeutic impasses. These medicinal products are based on the use of “drug” cells. However, the manufacture of these drugs requires the implementation of complex and therefore costly technologies. MiMédi’s ambition is to streamline their manufacturing by providing new technical solutions and optimising all the steps necessary for t...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 12,871 bytes −1,403‎ ‎Removed claim: summary (P836): Recentemente sono emersi medicinali innovativi (medii) al fine di offrire nuove soluzioni terapeutiche ai pazienti con impasse terapeutica. Questi medicinali sono basati sull'uso di cellule "farmaci". Tuttavia, la produzione di questi farmaci richiede l'attuazione di tecnologie complesse e quindi costose. L'ambizione di MiMédi è di razionalizzare la loro produzione fornendo nuove soluzioni tecniche e ottimizzando tutte le fasi necessarie per l...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 14,274 bytes −1,394‎ ‎Removed claim: summary (P836): Innovative medicines (medium) have recently emerged to propose new treatment solutions for patients with therapeutic deadlocks. These media are based on the use of “drug” cells. However, the manufacture of these drugs requires the implementation of complex and therefore costly technologies. MiMédi aims to streamline their manufacturing by providing new technical solutions and optimising all the steps necessary for their production. To do so, M...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 15,668 bytes −1,456‎ ‎Removed claim: summary (P836): Recientemente han surgido medicamentos innovadores (medios) con el fin de ofrecer nuevas soluciones de tratamiento para pacientes con estancamientos terapéuticos. Estos medicamentos se basan en el uso de células «fármacas». Sin embargo, la fabricación de estos medicamentos requiere la aplicación de tecnologías complejas y, por lo tanto, costosas. La ambición de MiMédi es optimizar su fabricación proporcionando nuevas soluciones técnicas y opti...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 17,124 bytes −1,403‎ ‎Removed claim: summary (P836): Recentemente sono emersi medicinali innovativi (medii) al fine di offrire nuove soluzioni terapeutiche ai pazienti con impasse terapeutica. Questi medicinali sono basati sull'uso di cellule "farmaci". Tuttavia, la produzione di questi farmaci richiede l'attuazione di tecnologie complesse e quindi costose. L'ambizione di MiMédi è di razionalizzare la loro produzione fornendo nuove soluzioni tecniche e ottimizzando tutte le fasi necessarie per l...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 18,527 bytes −1,445‎ ‎Removed claim: summary (P836): Er zijn onlangs innovatieve (middelmatige) geneesmiddelen ontstaan om nieuwe behandelingsoplossingen te bieden aan patiënten met therapeutische impasses. Deze geneesmiddelen zijn gebaseerd op het gebruik van „geneesmiddelen” cellen. Voor de vervaardiging van deze geneesmiddelen zijn echter complexe en dus dure technologieën nodig. De ambitie van MiMédi is om hun productie te stroomlijnen door nieuwe technische oplossingen te bieden en alle sta...
• curprev 13:5113:51, 16 May 2022‎ Admin talk contribs‎ 19,972 bytes −1,459‎ ‎Removed claim: summary (P836): Innovative (Medien-)Arzneimittel sind in jüngster Zeit entstanden, um neue Behandlungslösungen für Patienten in therapeutischen Sackgassen anzubieten. Diese Arzneimittel basieren auf der Verwendung von „Arzneimitteln“ Zellen. Die Herstellung dieser Arzneimittel erfordert jedoch die Anwendung komplexer und damit kostspieliger Technologien. MiMédi hat sich zum Ziel gesetzt, ihre Fertigung zu rationalisieren, indem sie neue technische Lösungen be...
• curprev 13:4413:44, 16 May 2022‎ DG Regio talk contribs‎ 21,431 bytes +6,470‎ ‎Merged Item from Q190706

14 January 2022

• curprev 03:1103:11, 14 January 2022‎ DG Regio talk contribs‎ 14,961 bytes +1,531‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

13 January 2022

• curprev 09:5009:50, 13 January 2022‎ DG Regio talk contribs‎ 13,430 bytes +1,478‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

6 December 2021

• curprev 17:5317:53, 6 December 2021‎ DG Regio talk contribs‎ 11,952 bytes +1,520‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

1 December 2021

• curprev 10:3110:31, 1 December 2021‎ DG Regio talk contribs‎ 10,432 bytes +1,459‎ ‎Created claim: summary (P836): Innovative (Medien-)Arzneimittel sind in jüngster Zeit entstanden, um neue Behandlungslösungen für Patienten in therapeutischen Sackgassen anzubieten. Diese Arzneimittel basieren auf der Verwendung von „Arzneimitteln“ Zellen. Die Herstellung dieser Arzneimittel erfordert jedoch die Anwendung komplexer und damit kostspieliger Technologien. MiMédi hat sich zum Ziel gesetzt, ihre Fertigung zu rationalisieren, indem sie neue technische Lösungen bere...

27 November 2021

• curprev 14:1614:16, 27 November 2021‎ DG Regio talk contribs‎ 8,973 bytes −1,530‎ ‎Removed claim: summary (P836): Les médicaments innovants (Médi) ont récemment émergé afin de suggestr de nouvelles solutions de traitement pour les patienten en impasse thérapeutique. CES Médi sont basés sur l’utilization de cellules „médicaments“. Oder, la fabrication de ces médicaments nécessite de mettre en oeuvre des technologies complexes et donc coûteuses. MiMédi a pour ambition de rationalizer leur fabrication en apportant de nouvelles solutions techniques et en opti...
• curprev 01:2501:25, 27 November 2021‎ DG Regio talk contribs‎ 10,503 bytes +1,530‎ ‎Created claim: summary (P836): Les médicaments innovants (Médi) ont récemment émergé afin de suggestr de nouvelles solutions de traitement pour les patienten en impasse thérapeutique. CES Médi sont basés sur l’utilization de cellules „médicaments“. Oder, la fabrication de ces médicaments nécessite de mettre en oeuvre des technologies complexes et donc coûteuses. MiMédi a pour ambition de rationalizer leur fabrication en apportant de nouvelles solutions techniques et en optimi...

26 November 2021

• curprev 16:1916:19, 26 November 2021‎ DG Regio talk contribs‎ 8,973 bytes +75‎ ‎Changed label, description and/or aliases in de: translated_label

24 November 2021

• curprev 18:1418:14, 24 November 2021‎ DG Regio talk contribs‎ 8,898 bytes +431‎ ‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string

22 November 2021

• curprev 11:2811:28, 22 November 2021‎ DG Regio talk contribs‎ 8,467 bytes +75‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 11:2811:28, 22 November 2021‎ DG Regio talk contribs‎ 8,392 bytes +1,404‎ ‎Created claim: summary (P836): Innovative (medium) medicines have recently emerged in order to offer new treatment solutions for patients with therapeutic impasses. These medicinal products are based on the use of “drug” cells. However, the manufacture of these drugs requires the implementation of complex and therefore costly technologies. MiMédi’s ambition is to streamline their manufacturing by providing new technical solutions and optimising all the steps necessary for the...

17 November 2021

• curprev 16:5916:59, 17 November 2021‎ DG Regio talk contribs‎ 6,988 bytes +3‎ ‎Changed label, description and/or aliases in en: Setting new description
• curprev 16:5916:59, 17 November 2021‎ DG Regio talk contribs‎ 6,985 bytes +6,985‎ ‎Created a new Item: importing one item from France